Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Ascendis Pharma A/S ASND

Full chart Compare
Set alert

Price alert · ASND

All alert types
250.17 USD +1.19 (+0.48%)

At closeNov 3, 2026, 4:00 PM EST

250.17 0.00 0.00%

After hours · Nov 3, 4:00 PM ET

248.57 Day range 252.75
188.07 52-week range 282.15
YTD
+17.32%
1 year
+24.48%

Financial health

Altman Z-Score

10.23 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B3 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 2
  • P/E 3
  • P/B 1

Valuation

P/E -50.1×
FY 2016: -7.4×FY 2017: -9.0×FY 2018: -17.2×FY 2019: -26.5×FY 2020: -16.5×FY 2021: -16.9×FY 2022: -11.0×FY 2023: -13.3×FY 2024: -20.4×FY 2025: -50.1×
FY 2016 5y median -16.9× FY 2025
P/S 15.9×
FY 2016: 111×FY 2017: 729×FY 2018: 212×FY 2019: 431×FY 2020: 993×FY 2021: 833×FY 2022: 125×FY 2023: 24.0×FY 2024: 21.2×FY 2025: 15.9×
FY 2016 5y median 24.0× FY 2025
P/B -67.6×
FY 2016: 2.9×FY 2017: 6.0×FY 2018: 8.0×FY 2019: 9.7×FY 2020: 8.2×FY 2021: 7.3×FY 2022: 24.3×FY 2023: -44.0×FY 2024: -72.8×FY 2025: -67.6×
FY 2016 5y median -44.0× FY 2025
P/FCF 252×
FY 2016: -8.4×FY 2017: -11.6×FY 2018: -15.9×FY 2019: -31.9×FY 2020: -23.6×FY 2021: -14.7×FY 2022: -12.5×FY 2023: -13.7×FY 2024: -25.0×FY 2025: 252×
FY 2016 5y median -13.7× FY 2025
EV/EBITDA -103×
FY 2016: -4.9×FY 2017: -7.4×FY 2018: -15.2×FY 2019: -24.8×FY 2020: -15.7×FY 2021: -17.1×FY 2022: -12.4×FY 2023: -16.5×FY 2024: -27.6×FY 2025: -103×
FY 2016 5y median -17.1× FY 2025
EV/Sales 16.3×
FY 2016: 71.7×FY 2017: 601×FY 2018: 186×FY 2019: 389×FY 2020: 923×FY 2021: 803×FY 2022: 128×FY 2023: 25.4×FY 2024: 22.0×FY 2025: 16.3×
FY 2016 5y median 25.4× FY 2025
FCF Yield 0.4%
FY 2016: -11.9%FY 2017: -8.6%FY 2018: -6.3%FY 2019: -3.1%FY 2020: -4.2%FY 2021: -6.8%FY 2022: -8.0%FY 2023: -7.3%FY 2024: -4.0%FY 2025: 0.4%
FY 2016 5y median -6.8% FY 2025

Profitability

Gross Margin 85.1%
FY 2016: 100.0%FY 2017: 100.0%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 54.7%FY 2022: 76.3%FY 2023: 83.4%FY 2024: 87.8%FY 2025: 85.1%
FY 2016 5y median 83.4% FY 2025
Operating Margin -18.9%
FY 2016: -1583.2%FY 2017: -7290.3%FY 2018: -1462.6%FY 2019: -1695.1%FY 2020: -4755.1%FY 2021: -5808.6%FY 2022: -1097.9%FY 2023: -170.8%FY 2024: -76.7%FY 2025: -18.9%
FY 2016 5y median -170.8% FY 2025
Net Margin -31.7%
FY 2016: -1487.3%FY 2017: -8097.8%FY 2018: -1229.5%FY 2019: -1630.0%FY 2020: -6025.5%FY 2021: -4931.6%FY 2022: -1139.6%FY 2023: -180.5%FY 2024: -104.0%FY 2025: -31.7%
FY 2016 5y median -180.5% FY 2025
ROE 134.6%
FY 2016: -38.8%FY 2017: -66.2%FY 2018: -46.5%FY 2019: -36.5%FY 2020: -50.0%FY 2021: -43.4%FY 2022: -221.5%FY 2023: 330.4%FY 2024: 357.7%FY 2025: 134.6%
FY 2016 5y median 134.6% FY 2025
ROIC -18.2%
FY 2016: -41.2%FY 2017: -59.4%FY 2018: -55.1%FY 2019: -35.7%FY 2020: -35.4%FY 2021: -45.2%FY 2022: -70.3%FY 2023: -86.8%FY 2024: -36.5%FY 2025: -18.2%
FY 2016 5y median -45.2% FY 2025
ROA -16.8%
FY 2016: -36.0%FY 2017: -58.7%FY 2018: -40.8%FY 2019: -32.2%FY 2020: -42.8%FY 2021: -35.4%FY 2022: -53.5%FY 2023: -58.3%FY 2024: -32.1%FY 2025: -16.8%
FY 2016 5y median -35.4% FY 2025

Growth (YoY)

Revenue 90.2%
FY 2016: -43.3%FY 2017: -66.8%FY 2018: 591.6%FY 2019: 26.4%FY 2020: -48.0%FY 2021: 11.9%FY 2022: 557.9%FY 2023: 421.2%FY 2024: 36.3%FY 2025: 90.2%
FY 2016 FY 2025
Operating Income 53.0%
FY 2016: -74.3%FY 2017: -53.0%FY 2018: -38.7%FY 2019: -46.5%FY 2020: -45.8%FY 2021: -36.6%FY 2022: -24.4%FY 2023: 18.9%FY 2024: 38.8%FY 2025: 53.0%
FY 2016 FY 2025
EPS (diluted) 44.6%
FY 2016: -85.6%FY 2017: -42.6%FY 2018: 13.9%FY 2019: -47.9%FY 2020: -76.5%FY 2021: 15.5%FY 2022: -48.6%FY 2023: 17.8%FY 2024: 23.6%FY 2025: 44.6%
FY 2016 FY 2025
Free Cash Flow 114.2%
FY 2016: -36.7%FY 2017: -57.8%FY 2018: -47.3%FY 2019: -28.0%FY 2020: -61.8%FY 2021: -50.8%FY 2022: -15.5%FY 2023: 7.9%FY 2024: 34.5%FY 2025: 114.2%
FY 2016 FY 2025

Financial Health

Current Ratio 1.0×
FY 2016: 13.7×FY 2017: 8.6×FY 2018: 7.5×FY 2019: 12.7×FY 2020: 14.0×FY 2021: 8.0×FY 2022: 1.3×FY 2023: 1.0×FY 2024: 1.2×FY 2025: 1.0×
FY 2016 5y median 1.2× FY 2025
Quick Ratio 0.8×
FY 2016: 13.7×FY 2017: 8.6×FY 2018: 7.5×FY 2019: 12.7×FY 2020: 14.0×FY 2021: 7.3×FY 2022: 1.1×FY 2023: 0.7×FY 2024: 0.8×FY 2025: 0.8×
FY 2016 5y median 0.8× FY 2025
Debt / Equity -5.4×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.2×FY 2022: 2.3×FY 2023: -5.1×FY 2024: -8.1×FY 2025: -5.4×
FY 2016 5y median -5.1× FY 2025
Net Debt / EBITDA -2.3×
FY 2016: 2.6×FY 2017: 1.6×FY 2018: 2.1×FY 2019: 2.7×FY 2020: 1.2×FY 2021: 0.6×FY 2022: -0.3×FY 2023: -0.9×FY 2024: -1.0×FY 2025: -2.3×
FY 2016 5y median -0.9× FY 2025
Interest Coverage -1.7×
FY 2016: -14584×FY 2017: -1150×FY 2018: -1219×FY 2019: -186×FY 2020: -172×FY 2021: -116×FY 2022: -18.3×FY 2023: -10.3×FY 2024: -4.3×FY 2025: -1.7×
FY 2016 5y median -10.3× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31